Research transparency

Transparency in research builds trust. We champion openness at every stage - from registering studies to sharing results - so participants, professionals, and the public can access and benefit from research outcomes.

Why transparency matters

Being transparent about your research builds trust and ensures ethical practice. It enables participants, researchers, clinicians, policymakers, and funders to:

  • Discover what studies are happening and their outcomes
  • Support informed decision-making
  • Build upon previous research to avoid duplication

Core responsibilities under the UK policy framework

Researchers, sponsors, and funders must uphold transparency in four key areas:

  1. Registering research
  2. Reporting results
  3. Notifying participants of outcomes
  4. Sharing study data and tissue

What you need to do

At the design stage - plan for transparency from the outset - whether it’s registering the study, producing lay summaries, or considering how results will be communicated.

After completion - share results - positive or negative - within 12 months via registries or publicly accessible, open-access platforms.

Communicate clearly - offer plain-language (lay) summaries so participants and the public can understand and engage with research findings.

Make it public

The HRA’s 'Make It Public' initiative promotes a culture where transparency is easy, expected, and visible:

  • Automating clinical trial registration using submitted approval data
  • Prompting timely reporting of results
  • Enabling meaningful feedback to participants

Research participants often express frustration when they don’t hear about study results. The strategy responds directly to this feedback by promoting the timely and understandable publication of findings.

HRA Make it Public strategy

Key Commitments:

  • Make transparency easy: Provide clear expectations, guidance, supportive systems, and reminders for researchers and sponsors.
  • Make transparency the norm: Collaborate with funders and regulators to align requirements, celebrate good practice, and address poor performance.
  • Make information public: Ensure all clinical trials are registered early, results and summaries are accessible, and public-facing content is understandable.

Useful links